Cargando…
Characterization of the aminopyridine derivative KRC-180 as a JAK2 inhibitor
Janus kinase 2 (JAK2) is a non-receptor tyrosine kinase that regulates the signal transducer and activator of transcription (STAT) signaling pathway. Deregulation of JAK2 signaling has previously been observed in hematologic malignancies, including erythroleukemia. In the present study, an aminopyri...
Autores principales: | Yoon, Kyoung Bin, Cho, Sung Yun, An, Su Jin, Park, Kyeong Ryang, Lee, Hyo Jeong, Yoon, Hae Sung, Lee, Sun-Mi, Kim, Yong-Chul, Han, Sun-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529941/ https://www.ncbi.nlm.nih.gov/pubmed/28789350 http://dx.doi.org/10.3892/ol.2017.6353 |
Ejemplares similares
-
Resistance to the c-Met inhibitor KRC-108 induces the epithelial transition of gastric cancer cells
por: KIM, DONG CHUL, et al.
Publicado: (2016) -
Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects
por: Lee, Hyo Jeong, et al.
Publicado: (2022) -
Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells
por: Ndolo, Karyn Muzinga, et al.
Publicado: (2017) -
Discovery of an Indirubin Derivative as a Novel c-Met Kinase Inhibitor with In Vitro Anti-Tumor Effects
por: Ndolo, Karyn Muzinga, et al.
Publicado: (2019) -
Schnurri-3 (KRC) Interacts with c-Jun to Regulate the IL-2 Gene in T Cells
por: Oukka, Mohamed, et al.
Publicado: (2004)